Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
1.
Prog Community Health Partnersh ; 6(1): 95-102, 2012.
Artigo em Inglês | MEDLINE | ID: mdl-22643793

RESUMO

PROBLEM: This paper argues that it is necessary to strengthen Asian American, Native Hawaiian, and Pacific Islander (AA and NHPI) community-based participatory research (CBPR) models that integrate a health policy agenda through dynamic legislative partnerships. PURPOSE: We utilize a case study approach and examine three health research partnership models that impact legislative design and action: The California Program on Access to Care (CPAC), the California Health Benefits Review Program (CHBRP), and the University of California Asian American and Pacific Islander Policy Multicampus Research Program (UC AAPI Policy MRP). KEY POINTS: In-depth examination reveals the difficulties of engaging in research that collaborates with multiple parties simultaneously and the specific benefits and challenges in each case. CONCLUSIONS: New directions are needed to deepen legislative engagement potential in CBPR and the translation of policy research that considers the health of all AA and NHPI communities.


Assuntos
Asiático/etnologia , Pesquisa Participativa Baseada na Comunidade/organização & administração , Pesquisa sobre Serviços de Saúde/organização & administração , Havaiano Nativo ou Outro Ilhéu do Pacífico/etnologia , Pesquisa Participativa Baseada na Comunidade/economia , Pesquisa Participativa Baseada na Comunidade/legislação & jurisprudência , Relações Comunidade-Instituição , Financiamento Governamental , Política de Saúde/economia , Política de Saúde/legislação & jurisprudência , Acessibilidade aos Serviços de Saúde/legislação & jurisprudência , Acessibilidade aos Serviços de Saúde/normas , Pesquisa sobre Serviços de Saúde/economia , Pesquisa sobre Serviços de Saúde/legislação & jurisprudência , Humanos , Modelos Organizacionais , Apoio à Pesquisa como Assunto/legislação & jurisprudência , Governo Estadual , Universidades
2.
Gastrointest Endosc ; 72(1): 33-43, 2010 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-20430384

RESUMO

BACKGROUND: Endoscopic surveillance of presumed-benign gastric ulcers may detect missed malignancy, but its impact on long-term outcomes is uncertain. OBJECTIVE: To estimate the clinical benefits and cost-effectiveness of follow-up surveillance. DESIGN: State-transition model. SETTING: To simulate the clinical course of presumed-benign gastric ulcers, we estimated prevalence and incidence of undetected gastric cancer, surveillance effectiveness, stage-specific disease mortality rates, and costs from clinical studies and databases. PATIENTS: This study involved 60-year-old men diagnosed with presumed-benign gastric ulcers. INTERVENTION: Follow-up endoscopic surveillance. MAIN OUTCOME MEASUREMENTS: Lifetime gastric cancer risk, life expectancy, quality-adjusted life expectancy, lifetime costs, and incremental cost-effectiveness ratios. RESULTS: For a cohort of 60-year-old men with presumed-benign gastric ulcers and a 2.6% prevalence of undetected malignancy, the lifetime gastric cancer risk was 4.4%. Surveillance improved (undiscounted) life expectancy by 10.0 days and increased discounted quality-adjusted life expectancy by 3.4 days at a cost of $146,700 per quality-adjusted life year (QALY). Surveillance cost less than $50,000 per QALY if the undetected gastric cancer prevalence was 6.5%, and it cost less than $100,000 per QALY if the prevalence was greater than 3.5%, endoscopy costs were 40% lower, or the disutility associated with gastric cancer was 30% lower. Probabilistic sensitivity analysis suggested that at a willingness-to-pay threshold of $100,000 per QALY, the probability that surveillance was cost effective was 25.2%. LIMITATIONS: Data from multiple sources with varied study designs were used. CONCLUSION: Endoscopic surveillance of presumed-benign gastric ulcers may improve overall survival. However, unless the prevalence of having undetected malignancy exceeds 6%, surveillance is unlikely to be cost-effective.


Assuntos
Assistência ao Convalescente/economia , Gastroscopia/economia , Infecções por Helicobacter/economia , Helicobacter pylori , Neoplasias Gástricas/economia , Úlcera Gástrica/economia , Análise Custo-Benefício , Técnicas de Apoio para a Decisão , Seguimentos , Infecções por Helicobacter/epidemiologia , Infecções por Helicobacter/mortalidade , Infecções por Helicobacter/patologia , Humanos , Masculino , Cadeias de Markov , Pessoa de Meia-Idade , Prognóstico , Anos de Vida Ajustados por Qualidade de Vida , Neoplasias Gástricas/epidemiologia , Neoplasias Gástricas/mortalidade , Neoplasias Gástricas/patologia , Úlcera Gástrica/epidemiologia , Úlcera Gástrica/mortalidade , Úlcera Gástrica/patologia , Taxa de Sobrevida
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA